Profile image of Sven Gallasch

Dr Sven Gallasch



Senior Lecturer


Faculty of Business and Law


Deakin Law School


Melbourne Burwood Campus

+61 3 924 68176


Sven Gallasch is a Lecturer at Deakin Law School. Originally educated at the University of Trier and the University of Augsburg in Germany, Sven holds a German Diploma in Law. He has also been awarded with a LLM in Competition Law and Policy (2009) and a PhD in Law (2014) from the University of East Anglia, Norwich, United Kingdom. His doctoral thesis is entitled ‘The anticompetitive misuse of intellectual property rights in the European pharmaceutical sector’ and was passed without corrections.

He frequently publishes in the area of pharmaceutical antitrust and engages with policy makers and other stakeholders at an international level. He was invited to deliver the keynote speech during the 7th United Nations Conference to Review the UN Set on Competition Policy and participated in the Round Table on The Role of Competition in the Pharmaceutical Sector and its Benefits for Consumers at UNCTAD in Geneva. He was also invited to talk about specific pharmaceutical antitrust issues by the Japan Fair Trade Commission in Tokyo and by the Federal Antimonopoly Service in Moscow.

Sven has also recently been appointed as the permanent national contributor for Australia by the European Competition Law Review.

Previously, Sven held teaching positions in Australia (Swinburne Law School, Melbourne), the United Kingdom (University of East Anglia where he was also  a Faculty Member of the Centre for Competition Policy) and in the United States as Visiting Professor (University of Stetson College of Law in Gulfport, Florida where he taught European Antitrust in the JD Program).

Sven is one of the initiators and Co-investigators of OpenLab Africa, which is a multinational and interdisciplinary research collaboration that aims to develop natural product medicines for neglected tropical diseases in the sub-Saharan region.

Most recently, he co-established the Transnational Lawyering Consortium between Deakin Law School, Western Sydney Law School and Indonesian partners which facilates transnational research collaborations and transnational education.

His most recent research project 'Informal cooperation and transnational convergence in competition policy' is funded by Deakin University and has received support from the Research Partnership Platform at UNCTAD.

Read more on Sven's profile

Knowledge areas

  • Competition Law
  • Intellectual Property Law
  • Pharmaceuticals
  • Transnational Legal Studies
  • Commercial Law


Informal cooperation and transnational convergence in Competition Policy (2023) funded by Deakin and supported by the United Nations Conference for Trade and Development (UNCTAD) Rearch Partnership Platform


Competition law and corporate determinants of health - Exploring the potential of competition law to improve public health outcomes, (2023) collaborative project with the Global Centre for Preventive Health and Nutrition (GLOBE) (funded by the Institute for Health Transformation


Filter by


Pay for delay 2.0: Anticompetitive early generic entry agreements in the Australian pharmaceutical sector

Sven Gallasch

(2023), Vol. 30, pp. 44-65, Competition and Consumer Law Journal, Sydney, N.S.W., C1

journal article

Quo Vadis - Australian merger reform and the choice between mandatory pre-notification and ex post administrative powers

Sven Gallasch

(2023), ECLR: European Competition Law Review, London, Eng., C1

journal article

Protecting competition in times of crisis - the balancing act looked at from a land Down Under

Sven Gallasch

(2021), Vol. 42, pp. 445-452, ECLR: European Competition Law Review, London, Eng., C1-1

journal article

Pay for delay in perspective: the impact of adversarial and inquisitorial legalism on pharmaceutical antitrust enforcement

Sven Gallasch

(2020), pp. 336-364, Research Handbook on Methods and Models of Competition Law, Cheltenham, Eng., B1-1

book chapter

Should pay for delay be a cause for concern in Japan?

S Gallasch, N Mariyama

(2020), Vol. 43, pp. 163-184, World Competition, Alphen aan den Rijn, The Netherlands, C1-1

journal article

The antitrust duck test: principled pragmatism on pharmaceutical antitrust

Sven Gallasch

(2019), Vol. 40, pp. 1-11, ECLR: European Competition Law Review, London, Eng., C1-1

journal article

A new dimension to EU pharma antitrust product hopping and unilateral pay for delay

S Gallasch

(2016), Vol. 12, pp. 137-158, European Competition Journal, Abingdon, Eng., C1-1

journal article

Activating actavis in Europe - The proposal of a 'structured effects-based' analysis for pay-for-delay settlements

S Gallasch

(2016), Vol. 36, pp. 683-705, Legal Studies, Cambridge, Eng., C1-1

journal article

Tolerance of salinized floodplain conditions in a naturally occurring Eucalyptus hybrid related to lowered plant water potential

T Zubrinich, B Loveys, S Gallasch, J Seekamp, S Tyerman

(2000), Vol. 20, pp. 953-963, TREE PHYSIOLOGY, C1-1

journal article

Funded Projects at Deakin

No Funded Projects at Deakin found


No completed student supervisions to report